載入中
Fee Standards for Biological Products, Centers for Disease Control, Ministry of Health and Welfare
1.中華民國九十八年四月二十九日行政院衛生署署授疾字第 0980000318 號令訂定發布全文 5 條；並自發布日施行 中華民國一百零二年七月十九日行政院院臺規字第 1020141353 號公告 本標準之主管機關原為「行政院衛生署疾病管制局」，自一百零二年七 月二十三日起變更為「衛生福利部疾病管制署」，第 2 條所列屬主管 機關掌理事項，改由「衛生福利部疾病管制署」管轄 2.中華民國一百零二年十二月三十一日衛生福利部部授疾字第 102010393 3 號令修正發布名稱、第 2、5 條條文及第 4 條條文之附表；除第 4 條附表自一百零三年一月一日施行外，自發布日施行 （原名稱：行政院衛生署疾病管制局生物製劑收費標準；新名稱：衛生 福利部疾病管制署生物製劑收費標準） 3.中華民國一百零五年十一月二日衛生福利部部授疾字第 1050101155 號 令修正發布全文 5 條；並自一百零六年一月一日施行 4.中華民國一百零八年五月十日衛生福利部衛授疾字第 1080100440 號令 修正發布第 5 條條文及第 4 條附表；並自一百零八年七月一日施行
資料來源：全國法規資料庫（ChOrder.json，版本 2026/7/24 上午 12:00:00）・政府資料開放授權
This set of Standards is formulated in accordance with the regulations of Article 10 of the Charge And Fees Act.
This set of Standards applies to the biological products manufactured and commissioned for production by the Centers for Disease Control, Ministry of Health and Welfare.
The biological products mentioned in this set of Standards are Antivenins.
Items and fees charged for the manufactured and supplied biological products are as shown in the Attachment.
1This set of Standards shall enter into force on January 1, 2017.
2The Attachment to Article 4 of these standards, amended on May 10, 2019, shall enter into force on July 1, 2019.